Page last updated: 2024-09-03

muramylnac-ala-isogln-lys-tripeptide and ribavirin

muramylnac-ala-isogln-lys-tripeptide has been researched along with ribavirin in 1 studies

Compound Research Comparison

Studies
(muramylnac-ala-isogln-lys-tripeptide)
Trials
(muramylnac-ala-isogln-lys-tripeptide)
Recent Studies (post-2010)
(muramylnac-ala-isogln-lys-tripeptide)
Studies
(ribavirin)
Trials
(ribavirin)
Recent Studies (post-2010) (ribavirin)
504112,3161,8805,443

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnhart, D; Gangemi, JD; Jani, P; Krech, L; Nachtigal, M1

Other Studies

1 other study(ies) available for muramylnac-ala-isogln-lys-tripeptide and ribavirin

ArticleYear
Therapeutic efficacy of liposome-encapsulated ribavirin and muramyl tripeptide in experimental infection with influenza or herpes simplex virus.
    The Journal of infectious diseases, 1987, Volume: 155, Issue:3

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Drug Therapy, Combination; Herpes Simplex; Liposomes; Macrophage Activation; Macrophages; Mice; Mice, Inbred C3H; Orthomyxoviridae Infections; Phagocytosis; Pneumonia, Viral; Ribavirin; Ribonucleosides

1987